Participating organizations will have access to the National Advisory Committee, a panel of subject matter and clinical experts who will guide participants on developing objectives and educational content. Through this collaborative, participants will expand their quality improvement work, accelerate their pace of improvement in administering HPV vaccinations, and learn from one another in a peer-to-peer setting.
According to the Centers for Disease Control and Prevention, HPV causes an estimated 34,800 cancers of six different types in the United States each year. Widespread HPV vaccination has the potential to prevent 92% of those cancers. Vaccination may also lower healthcare costs by reducing the need for screenings and subsequent care.